A cannabinoid type 2 (CB2) receptor agonist augments NOS-dependent responses of cerebral arterioles during type 1 diabetes

Lauren Van Hove, Kirsten R. Kim, Denise M. Arrick, William G. Mayhan

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A cannabinoid type 2 (CB2) receptor agonist augments NOS-dependent responses of cerebral arterioles during type 1 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds